BIO Asia–Taiwan 2023 亞洲生技大會

BIO Asia–Taiwan 2023 亞洲生技大會


Bio-Techne Hong Kong Limited


Company Info

Name /Bio-Techne Hong Kong Limited

Address /Unit 208B, 2nd Floor, Photonics Center, Hong Kong Science Park, Tai Po, New Territories, Hong Kong

Website /


Name /Evan Lin

Title /Sales Manager

Email /

Telephone /

Fax /

Mobile /+886-937218884

Company Type


About the Company

Bio-Techne empowers researchers in Life Science and Clinical Diagnostics by providing high-quality reagents, instruments, custom manufacturing, and testing services. Our family of brands creates a unique portfolio of products and services.

Science is our passion; it drives us to collaborate, develop, and manufacture award-winning tools that help researchers achieve reproducible and consistent results. Whether you are at the cutting edge of academic research, translating basic discoveries to therapeutic leads, or at a facility that requires the highest level of diagnostic testing, our innovative products and services provide the solutions you need to achieve success.

Brief Description of main products or services

Bio-Techne Corporation Brands

R&D Systems entered the field of biotechnology early, becoming the first company to commercially market the multifunctional cytokine TGF-beta 1. R&D Systems has since established itself as a developer and manufacturer of high-quality proteins and the world leader in immunoassays as well as a producer of antibodies, arrays, stem cell products, cell selection and detection products among other cell biology tools.

Novus Biologicals produce and market antibodies to support niche and emerging areas of research. Novus is built on honesty, collaboration and strong relationships and will continue to provide quality tools to accelerate the bioscience research community.

Tocris is the leading supplier of novel, exclusive small molecules and peptides for life science research. Used in experiments to understand biological processes and diseases and as part of the initial drug-discovery process, Tocris reagents include receptor ligands, ion channel modulators, enzyme inhibitors, caged compounds, and screening libraries.

ACD is a leader in developing cell- and tissue-based diagnostic tests for personalized medicine. ACD’s RNAscope® Technology, the first multiplex fluorescent and chromogenic in situ hybridization platform capable of detecting and quantifying RNA biomarkers at single-molecule sensitivity. RNAscope® is used in proprietary diagnostic tests for cancer management and to validate biomarkers for targeted therapeutic development.

Contact Person

Name /Evan Lin

Email /

Phone /+886-937218884